Dr Voss Gibson•
The Weight Loss Pill in Australia: TGA Status, How It Compares, and What to Know (2026)
The Wegovy pill is one of the most anticipated medicines in Australia right now — a once-daily tablet containing the same active ingredient as the weekly weight-loss injection. It’s already available in the US, UK and Europe. Here’s exactly where it stands in Australia, how it compares to injections, what it’s likely to cost, and — importantly — why you should steer clear of anyone selling it to you before approval.
Is the Wegovy Pill Available in Australia?
Not yet. The TGA has stated that it “has accepted and commenced evaluation of an application to register the oral tablet formulation of Wegovy (semaglutide).” A second oral option is also in the queue: the TGA lists orforglipron as a new medicine under evaluation, from Eli Lilly, accepted in January 2026; it is not yet on the ARTG.
Overseas, the tablet is further along. It was approved in the US in December 2025, and on 11 June 2026, the United Kingdom’s regulator approved Wegovy tablets for weight management. The European Commission followed in July.
On timing, a daily weight-loss tablet containing the same active ingredient as Ozempic and Wegovy could reach Australian pharmacies as early as Christmas 2026. If the paperwork drags, mid-2027 is the fallback date. Treat those as informed estimates, not commitments — regulatory decisions don’t run to a fixed clock.
Two important distinctions: TGA approval is not the same as PBS subsidy, and Rybelsus — an existing oral semaglutide tablet — is TGA-approved for type 2 diabetes only. It isn’t a weight-loss pill and isn’t interchangeable with the forthcoming Wegovy tablet.
Pill vs Injection vs Orforglipron: How They Compare
| Wegovy injection | Wegovy tablet | Orforglipron | |
|---|---|---|---|
| :Active ingredient | Wegovy injection:Semaglutide | Wegovy tablet:Semaglutide | Orforglipron:Orforglipron (small molecule) |
| :How often | Wegovy injection:Once weekly | Wegovy tablet:Once daily | Orforglipron:Once daily |
| :Food rules | Wegovy injection:None | Wegovy tablet:Strict (empty stomach) | Orforglipron:Fewer restrictions |
| :Australian status | Wegovy injection:Approved since Feb 2025 | Wegovy tablet:Under TGA evaluation | Orforglipron:Under TGA evaluation |
The tablet works the same way as the injection. The pill contains the same active ingredient as Ozempic and Wegovy, taken once daily as a tablet rather than a weekly injection. In the main clinical trial (OASIS-4), weight loss on the high-dose tablet was broadly comparable to the injection — though individual results vary considerably.
Orforglipron is different under the hood. It’s a small-molecule medicine rather than a peptide, which is why it’s expected to have fewer food-timing restrictions. Both will need individual assessment by a doctor, and neither suits everyone.
The real appeal is removing the needle. As one GP noted, many patients simply refuse a weekly needle, no matter how effective it is.
How the Pill Is Taken
The tablet is less forgiving than the injection about timing. The tablet has to be taken on an empty stomach with plain water, then nothing to eat for 30 minutes. That’s because food in the stomach sharply reduces how much semaglutide is absorbed.
For some people this daily routine is easy; for others, a weekly injection is genuinely simpler. It’s a practical trade-off worth discussing with your doctor. Side effects are expected to mirror the injection — mainly nausea, diarrhoea and constipation, especially as the dose increases.
Cost: What to Expect
No Australian price has been set. For context, injectable Wegovy costs about $269 to $460 a month on a private script in Australia because obesity treatment isn’t subsidised on the PBS.
Some clinicians expect the tablet to be competitive. British patients already have access to the tablet and pay around $5.80 per day. One Australian GP has suggested it could undercut injections by 10 to 20 per cent — but that’s a prediction, not a confirmed price. Realistically, without a PBS subsidy the tablet would be full price from day one.
⚠️ The Counterfeit Tablet Warning
This is the most important section of the article. The anticipation around weight-loss pills has created a market for fakes.
Any GLP-1 tablet for weight offered in Australia before TGA approval would be an unapproved medicine. The TGA tested imported “GLP-1” oral products in 2026 and found no GLP-1 in them. In other words, people paying for these products are getting something other than what’s on the label — at best useless, at worst unknown and potentially harmful.
Compounded alternatives aren’t a legal workaround either. The government banned pharmacies from compounding copycat semaglutide from 1 October 2024, so the approved products are the only legal route.
The red flags are simple: a website selling “GLP-1 tablets” or “semaglutide pills” for weight loss right now, products shipped from overseas, or any offer that doesn’t involve a genuine consultation with an Australian doctor.
What You Can Do Now
You don’t have to wait for the pill to get proper support. If weight is affecting your health, a doctor can assess whether a currently approved treatment is suitable for you today — and switching to a tablet later, once it’s approved, is a straightforward conversation.
A few things are worth doing regardless of which format you eventually use:
- Check your eligibility properly.
- Protect your muscle. Pill or injection, rapid weight loss can cost lean mass.
- Be honest about your relationship with food. Appetite-suppressing medicines need careful screening.
- Understand the options side by side.
We’ll update this page as soon as the TGA makes a decision.
